Nasdaq · Biotech stocks database
AYTU (Aytu BioPharma Inc.) stock: $1.83, $19.9M market cap, $26.3M cash, $3.1M EV, $43.8M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Company Overview Aytu BioPharma, Inc. (“Aytu,” the “Company,” “we,” “us,” or “our”) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. We were originally incorporated as Rosewind Corporation on August 9, 2002, in the state of Colorado and re-incorporated as Aytu BioScience, Inc. in the state of Delaware on June 8, 2015.
Source: 10-K FY2026 via SEC EDGAR
| Cash | $26.3M |
|---|---|
| Debt | $9.6M |
| Net cash | $16.8M |
| Enterprise value | $3.1M |
| Basic shares | 10.9M shares |
| Fully diluted shares | 23.9M shares |
| Fully diluted market cap | $43.8M |
| Cash per share | $2.42 |
| Quarterly burn | +$4.4M generated |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading AYTU daily closes…